Hi [[ session.user.profile.firstName ]]

Searching for adverse effects of medical devices in MEDLINE and Embase

In this webinar, Dr Su Golder NIHR Research Fellow, Health Sciences, at the University of York will discuss:

- Importance of medical device adverse effects
- Problems with searching for medical device adverse effects
- Approaches to searching for medical device adverse effects
- Research into search filters for medical device adverse effects

Dr Su Golder is a qualified information specialist with over 20 years' experience. She has worked in lots of different settings and has a wide breadth of experience in supporting systematic reviews of healthcare interventions. She has specialist expertise in systematic review methodology and systematic reviews of adverse effects and has taught in this field. Her PhD on optimising the retrieval of adverse effects data was funded by the MRC and has made an important contribution to the retrieval of information on adverse effects both nationally and internationally. Her current research is on the use of unpublished data, text mining and social media to maximise the efficiency and effectiveness of the retrieval of adverse effects data and has been funded by the National Institute for Health Research (NIHR) and began in January 2015 on a part-time basis.
Recorded Oct 18 2018 44 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Dr Su Golder NIHR Research Fellow, Health Sciences, University of York
Presentation preview: Searching for adverse effects of medical devices in MEDLINE and Embase

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
  • Automated extraction of adverse drug reactions using machine learning Feb 19 2020 3:00 pm UTC 60 mins
    Dr. Umesh Nandal, Principal NLP Scientist, Elsevier
    By combining content with cutting-edge technology in Artificial intelligence (AI), Machine learning (ML) and Natural language processing (NLP), we enable professionals to find the precise information they need to advance their research and make decisions that affect the lives of patients and whole societies. In pharmacovigilance, post-market surveillance is critical to the protection of public health and monitoring the diverse sources of information for cases of Adverse Drug Reactions (ADRs) is a critically important and time-consuming task. Automatic extraction of ADRs from both highly regularized and variably structured content could play an important role in augmenting the information about ADRs that is obtained during short-term clinical trials.

    In this webinar, Dr. Umesh Nandal, the Principal NLP Scientist at Elsevier will talk about
    - the challenges of literature mining using AI
    - the Biomedical Named Entity Recognition (BNER) and its advantages for information extraction tasks
    - how to create a quality training set for machine learning
    - the experiment outcome and further applications
  • Predicting drug-drug interactions to reduce adverse event risk Jan 16 2020 3:00 pm UTC 45 mins
    Marnix Wieffer
    Adverse drug reactions (ADRs) are a serious problem worldwide. One reason for the increase in ADRs is the growth in prescription use—especially among aging populations where drug–drug interactions (DDIs) are more likely. Currently, 9 percent of Americans over age 55 take 10 or more prescription drugs, which greatly increases the likelihood of DDIs and ADRs.

    Identifying potential drug-drug interaction risk is a key priority for pharmaceutical manufacturers and regulatory authorities. To minimize health risks to clinical trial subjects and patients, assessments should be performed as early as possible in development.
    Join solution marketing manager Dr Marnix Wieffer for this webinar where he will discuss outstanding issues with predicting Drug-drug interaction risk and possible solutions. We run through a couple of live examples that show how PharmaPendium is supporting Drug-drug interaction risk prediction.
    Using PharmaPendium we will investigate
    •What enzymes and transporters act on my drug of interest?
    •What is the DDI risk for drugs that are substrates CYP2D6?
    •What is the DDI risk of my drug under development with Antiarrhythmic drugs?
  • Practical data management for greater collaboration in pharma R&D Jan 14 2020 2:00 pm UTC 60 mins
    Ted Slater, Sr. Director of Product Management PaaS, Elsevier
    The Life sciences industry has always relied on empirical data in order to identify patterns, test theories and understand the efficacy of treatments. The increase in data - in volume, variety and velocity necessitates a digital transformation; moving to greater collaboration and more effective partnerships. This would require more clear and practical guidance on how data is captured and managed.

    In this webinar, Ted Slater – Sr. Director of Product Management PaaS will discuss
    •What are the FAIR data principles?
    •What are the benefits of creating and using FAIR data for drug discovery and development?
    •Elsevier’s initiatives in leverage the FAIR guiding principles, and
    •How to build around FAIR data principles to drive research programs

    About the speaker
    Ted Slater is Senior Director for Product Management PaaS at Elsevier. He is one of the authors on the seminal 2016 FAIR guiding principles paper and has held senior roles in large pharmaceutical and computing technology companies, content providers, and biotechs. He holds master’s degrees in Molecular Biology from the University of California at Riverside, and in Computer Science from New Mexico State University.
  • Relevance of index databases in navigating data and information in Chemistry Dec 10 2019 3:00 pm UTC 60 mins
    Jürgen Swienty-Busch, Elsevier and Ye Li, PhD, MLIS Chemistry and Chemical Engineering Librarian, MIT
    This webinar will examine how index databases can help navigate chemical information efficiently, and how the structured chemical data may enable innovative discoveries. Attendees will be able to:
    •Understand the intellectual value of chemical data and literature indexing
    •Explore functionalities based on indexing and taxonomy in databases
    •Recognize innovative and computational trends of using structured chemical data
  • Leverage PK data in PharmaPendium to inform drug development strategies Recorded: Dec 5 2019 49 mins
    Marnix Wieffer
    Pharmacokinetic information from FDA and EMA regulatory documents informs translational and clinical development decisions and may lead to more successful drug development and regulatory approval strategies.

    Pharmacokinetic information from FDA and EMA regulatory documents informs translational and clinical development decisions and may lead to more successful drug development and regulatory approval strategies.
    Join solution marketing manager Dr. Marnix Wieffer for this webinar, where he will discuss how to leverage extracted pharmacokinetic data from literature and FDA/EMA Drug Approval documents to make better-informed decisions on which drugs have the most potential to succeed in clinical development.

    Using PharmaPendium we will
    •Retrieve detailed information on PK parameters on approved drugs
    •Retrieve all data on PK parameter of interest (for example Cmax) on drug acting on the same target I am working on
    •Investigate what is the best translational model to assess Serum protein binding
    •And much more
  • Effective and Compliant Literature screening for Pharmacovigilance Recorded: Dec 3 2019 47 mins
    Jean Dominique Pierret
    Biomedical literature is an important source of adverse event reporting. However, due to the high volume of literature, sub-optimal search strategies and regulatory pressure, pharmaceutical companies and CROs are facing significant challenges around costs, efficiencies, oversight and regulations.

    During this webinar, Dr Jean Dominique Pierret, Customer Consultant Pharmacovigilance at Elsevier, will discuss how, through query design, prioritization technology and outsourcing we can significantly improve efficiency and compliance of literature screening.
    We will explore:
    1.The optimization of queries in literature databases
    2.The benefits if literature workflow management
    3.Efficiency gains through prioritization
    4.How outsourcing can support efficiency gains
  • Introduction into PharmaPendium: informed decision making during development Recorded: Oct 3 2019 43 mins
    Marnix Wieffer
    Optimal decisions making during pharmaceutical development critically relies on high quality data. PharmaPendium is the go-to database to access extracted data from regulatory documents and literature on approved drugs
    Join PharmaPendium Marketing Manager Dr. Marnix Wieffer for this introduction webinar where we will discuss why we need high quality extracted data on marketed drugs during drug development and provide an introduction in:
    -PharmaPendium’s unique document and data content
    -The expert taxonomies that help to unlock critical data
    -The benefits of both searching in full text through regulatory documents and accessing extracted data
    -Example use cases showing how we can work with PharmaPendium to uncover important reviewer insights by full text searching in regulatory documents
    -Gain translational inside by recovering extracted drug safety data
  • New Quosa Recorded: Sep 17 2019 51 mins
    Ken Karapetyan
    We will give updates on the status of the new Quosa, how it will be different from the existing Quosa. We will share the development roadmap and will discuss the migration plan.
  • PharmaPendium August release: Unlocking and sharing critical safety insights Recorded: Sep 5 2019 47 mins
    Marnix Wieffer
    Optimal decisions making during pharmaceutical development critically relies on high quality data. PharmaPendium is the go-to database to access extracted data from regulatory documents and literature on approved drugs

    Join PharmaPendium Marketing Manager Marnix Wieffer to discover the new features of the upcoming PharmaPendium release (week of 19 August) that will support uncovering critical safety insights and effective information sharing. We will discuss:
    1.Gain translational insights through improved Boolean operator drug safety searching
    2.Streamline information exchange through new sharing searches function
    3.Highlight critical post-market data through custom colouring of the FAERS heatmap

    The webinar includes demonstrations of all the new features and a Q&A session for attendees to get further information about PharmaPendium’s drug safety and data sharing workflows
  • Embase for drug analytics Recorded: Jun 20 2019 52 mins
    Dr. Erin van Buel
    Biomedical literature has a critical role in post-market surveillance and vigilance to ensure the safety and effectiveness of drugs and medical devices. In the meantime, data extracted from the literature is being more used in different stages of drug discovery and development to achieve different goals. Understanding the relationship between drug-disease, drug-drug, device-disease and device-device can provide important insights for drug development and re-positioning.

    In this webinar, Quality Control Scientist Dr. Erin van Buel will discuss
    •Indexing principles and relationships identified with in-depth indexing in Embase
    •How to use advanced search filters and features to identify semantic relationships between drugs and diseases, such as drugs used to treat a disease, drug-drug combination, drug-drug interaction, etc.
    •How the semantic relationships identified with in-depth indexing can be used to inform drug development, re-positioning and safety

    Date: Jun 20, 2019
    Time: 16:00 CET
  • Finding the right information for Medical Device CER and PMS Recorded: Apr 10 2019 40 mins
    Xuanyan Xu
    Information found in the biomedical literature is a significant source for every stage of the medical device life cycle, from concept and design through clinical trials to release and reimbursement, as well as post-market surveillance.

    In June 2016, the updated Medical Device Clinical Evaluation Report (CER) guidelines came into effect (Revision 4 of MEDDEV 2.7/1), detailing where and how to search for literature and how to record the process of collecting, appraising and analyzing the items found.

    In this session, Elsevier's solution manager Xuanyan Xu will demonstrate how Embase is especially suited to help Medical Device manufacturers prepare CER, including:

    - How to design effective literature searches for Clinical Evaluation reports using the PICO search form in Embase;
    - How to build a more comprehensive search using Emtree terms and synonyms;
    - How trade name and manufacturer name indexing supports analyses of devices already on the market;
    - How to find mentions of adverse device reactions in the literature for effective post-market surveillance (PMS) reporting
  • Introducing Embase French Local Literature Module Recorded: Feb 19 2019 49 mins
    Iveta Petrova
    Literature is one of the essential sources to identify high quality adverse drug reaction (ADR) reports. Regulatory authorities require companies to monitor major international publications through databases, as well as local, non-English content sources in each of the countries where the drugs are marketed. In November, 2018, Embase introduced the first non-English content – French Local Language Module, which is designed to screen, review and monitor French literature for pharmacovigilance.

    In this webinar, Embase product manager Iveta Petrova will discuss:
    -The challenges in Local Literature Monitoring process for pharmacovigilance
    -The concepts of Embase French Local Literature Module
    -How to use this module in Embase.com to build effective searches to identify the mention of drugs and ADRs in French journals

    About the speaker:
    Iveta Petrova holds a Ph.D. from Leiden University for research done on Wnt signaling in the nervous system. She joined the Embase team at Elsevier as part of the Content quality department. For 2 years she was responsible for writing and updating the indexing guidelines, as well as monitoring the quality of indexing. One year ago she joined the Product management team of Embase. Currently her tasks include continuous engagement with customers and market research to further improve and develop tools to support them in their daily responsibilities, specifically the enhancement of evidence-based medicine, pharmacovigilance and medical device clinical evaluation and safety.
  • Literature searching in Health Economics Recorded: Dec 3 2018 51 mins
    Julie Glanville, Associate Director at York Health Economics Consortium
    Please note: change of date!

    In this webinar, Julie Glanville , Associate Director at York Health Economics Consortium, will discuss literature searching in Health Economics.

    Health economics evidence is a key element in much health services research and particularly in health technology assessments. Health economic models are increasingly used to assist with health care decision making. Identifying economic evidence to inform such research can involve searches in a range of databases and using a variety of strategies.

    This webinar will summarize the key resources which can be searched to identify health economics information including economic evaluations and economic models. We will also explore how to design search strategies to find economic evaluations including economic models. With the closure of key economic evaluation databases (NHS EED and HEED) we will be focusing on how to identify economic evaluations from major bibliographic databases.

    Julie Glanville is Associate Director at York Health Economics Consortium, part of the University of York. Here, she manages systematic review and literature review projects. She also organizes the YHEC training programme.

    YHEC provides a range of research services including literature searches and evidence identification to inform research projects in healthcare topics but also in other fields such as food safety and feed safety, social care, housing, criminal justice and education. YHEC contributes to the evidence base for information retrieval with a special focus on identifying economic evidence and search filters (strategies) for a range of research methods.

    YHEC carries out systematic and non-systematic reviews for a range of clients to identify the effects of drugs, devices and other interventions. The training program also partners with Quantics Consulting to provide indirect treatment comparisons (ITCs) and mixed treatment comparisons (MTCs).
  • What's new in PharmaPendium? Recorded: Nov 6 2018 64 mins
    Pooja Jain
    Successful drug development requires anticipating safety and regulatory issues as early as possible. PharmaPendium is uniquely positioned to facilitate efficient translational studies of drug safety and efficacy. It supports risk assessment activities with unique access to valuable adverse event and approval documents alongside tools that maximise insights into drug safety and efficacy data.

    The 2018 development plan for PharmaPendium focused on strengthening this position as a support tool for early assessments of drug candidates.

    About this webinar
    Join PharmaPendium Product Manager Pooja Jain to discover the new features that facilitate efficient translational studies of drug safety and efficacy, including:

    - New search and filter capabilities that enable users to specifically search for pharmacokinetic, metabolizing enzyme and transporter data for concomitant drugs and other substances
    - Improvements to PharmaPendium’s unique FDA Adverse Event Reporting System (FAERS) search functionality, including a heatmap and percentage calculator, which make it easier to visualize and compare differences in adverse event reporting
    - Updates to the Drug–Drug Indication Risk Calculator (DDIRC) content to keep pace with user needs for drug–drug interaction (DDI) risk prediction
    - Updates to the MedDRA (Medical Dictionary for Regulatory Activities) taxonomy, which helps ensure that searches conform to the clinically validated international nomenclature used by regulatory authorities
    -Improvements to the Indications taxonomy and search capabilities that provide insight into approved vs tested/off-label indications
    - Email alerts to help users stay up to date on new content relevant for a given search

    The webinar includes demonstrations of all the new features and a Q&A session for attendees to get further information about PharmaPendium’s drug safety and efficacy workflows.
  • Introducing Embase French Local Literature Module Recorded: Oct 31 2018 47 mins
    Iveta Petrova, Embase Product Manager
    Literature is one of the essential sources to identify high quality ADR reports. Regulatory authorities require companies to monitor major international publications through databases, as well as local, non-English content sources in each of the countries where the drugs are marketed. Currently, the local, non-English content sources is not available in most international literature databases, therefore screening, reviewing and monitoring this type of literature costs extra time, money and creates an additional compliance risk.

    In this webinar, Embase product manager Iveta Petrova will discuss:
    -The challenges in Local Literature Monitoring process for pharmacovigilance, with a focus on the French market
    -The concepts of Embase French Local Literature Module
    -How to use this module in Embase.com to build effective searches to identify the mention of drugs and ADRs in French journals

    About the speaker:
    Iveta Petrova holds a Ph.D. from Leiden University for research done on Wnt signaling in the nervous system. She joined the Embase team at Elsevier as part of the Content quality department. For 2 years she was responsible for writing and updating the indexing guidelines, as well as monitoring the quality of indexing. One year ago she joined the Product management team of Embase. Currently her tasks include continuous engagement with customers and market research to further improve and develop tools to support them in their daily responsibilities, specifically the enhancement of evidence-based medicine, pharmacovigilance and medical device clinical evaluation and safety.
  • Enhancing key PV Solutions to boost the efficiency of drug safety workflows Recorded: Oct 23 2018 51 mins
    Sherry Winter, Senior Solution Marketing Manager at Elsevier
    Databases of peer-reviewed biomedical literature and regulatory documents are crucial sources for pharmacovigilance activities. When monitored properly, they yield drug safety signals that are essential for risk–benefit assessments and adverse event reports. However, both are vast resources that can be challenging to monitor efficiently and accurately, especially if different interfaces are needed to access each database.

    In 2018, Elsevier is enhancing key solutions for pharmaceutical R&D as part of ongoing efforts to improve the comprehensiveness, efficiency, accuracy and compliance of pharmacovigilance-focused research. By ensuring that all relevant information is captured efficiently, the company is helping drug safety and pharmacovigilance teams deliver considerable improvements in health-critical workflows.

    This webinar focuses on 2018 enhancements to Embase, PharmaPendium and QUOSA PV, showing how each solution offers dedicated means to boost the efficiency and accuracy of the monitoring of relevant databases, assessment of captured information, and supervision of the workflow. These enhancements include:
    - A dedicated Embase query form for efficient creation and validation of the complex search strings needed for high-recall, high-precision literature searching
    - An Embase French Local Language Module to extend the reach of Embase into specially selected French-language literature
    - More capabilities in PharmaPendium for searching the FDA Adverse Event Reporting System (FAERS)
    - Even more flexible means to run and oversee GxP-compliant workflows through QUOSA PV, with new functionalities for medical review, signal management and quality assurance. The webinar will address these solutions and enhancements in the context of comprehensive support for the goals of pharmacovigilance.
  • Searching for adverse effects of medical devices in MEDLINE and Embase Recorded: Oct 18 2018 44 mins
    Dr Su Golder NIHR Research Fellow, Health Sciences, University of York
    In this webinar, Dr Su Golder NIHR Research Fellow, Health Sciences, at the University of York will discuss:

    - Importance of medical device adverse effects
    - Problems with searching for medical device adverse effects
    - Approaches to searching for medical device adverse effects
    - Research into search filters for medical device adverse effects

    Dr Su Golder is a qualified information specialist with over 20 years' experience. She has worked in lots of different settings and has a wide breadth of experience in supporting systematic reviews of healthcare interventions. She has specialist expertise in systematic review methodology and systematic reviews of adverse effects and has taught in this field. Her PhD on optimising the retrieval of adverse effects data was funded by the MRC and has made an important contribution to the retrieval of information on adverse effects both nationally and internationally. Her current research is on the use of unpublished data, text mining and social media to maximise the efficiency and effectiveness of the retrieval of adverse effects data and has been funded by the National Institute for Health Research (NIHR) and began in January 2015 on a part-time basis.
  • Improved Synthetic Planning with Reaxys Procurement Integration- 5pm CET Recorded: Oct 17 2018 50 mins
    Scott Hutton, Commercial Director and Prima Sung, Sr. Solution Marketing Manager
    Laboratory scientists face many practical challenges in implementing a desired chemical synthesis. One major challenge is the ability to access accurate information on what starting materials are available in a company’s local inventory, as well as which suppliers may be used to purchase desired chemicals. Once materials are identified, how long will it take to get them? What is the company’s negotiated price for each material?

    Besides being clever scientists, medicinal chemists must be master logistics planners coordinating all the materials and documentation necessary to perform chemical synthesis on an ongoing basis. Elsevier understands the chemist’s synthetic work flow and has taken steps with Reaxys to enable integration with local chemical inventory and purchasing systems.

    Please join us for this webinar, in which we will focus on:

    - The challenges of identifying and purchasing critical starting materials for chemical synthesis planning
    - How your procurement system can be integrated with Reaxys to make this process easier while saving the organization time and money.
    - How additional data from your systems can be integrated with Reaxys to improve workflows and accelerate discovery.
  • Improved Synthetic Planning with Reaxys Procurement Integration - 9am CET Recorded: Oct 17 2018 45 mins
    Scott Hutton, Commercial Director and Prima Sung, Sr. Solution Marketing Manager
    Laboratory scientists face many practical challenges in implementing a desired chemical synthesis. One major challenge is the ability to access accurate information on what starting materials are available in a company’s local inventory, as well as which suppliers may be used to purchase desired chemicals. Once materials are identified, how long will it take to get them? What is the company’s negotiated price for each material?

    Besides being clever scientists, medicinal chemists must be master logistics planners coordinating all the materials and documentation necessary to perform chemical synthesis on an ongoing basis. Elsevier understands the chemist’s synthetic work flow and has taken steps with Reaxys to enable integration with local chemical inventory and purchasing systems.

    Please join us for this webinar, in which we will focus on:

    - The challenges of identifying and purchasing critical starting materials for chemical synthesis planning
    - How your procurement system can be integrated with Reaxys to make this process easier while saving the organization time and money.
    - How additional data from your systems can be integrated with Reaxys to improve workflows and accelerate discovery.
  • Librarians’ Role in Evidence-Based Medicine Education for Healthcare Policymaker Recorded: Sep 19 2018 54 mins
    Maylene Qiu, Systematic Review Coordinator and Clinical Liaison Librarian at Biomedical Library, University of Pennsylvania
    NOTE: NEW DATE!

    The practice of evidence-based medicine (EBM) requires retrieving the knowledge from ever-increasing volume of literature. Librarians have supported EBM by offering information searching skills and various tailored training programs.

    While users’ needs constantly drive library’s teaching activities, customizable EBM teaching modules have been developed to respond to different needs of library's constituencies, particularly the policy makers within a university’s healthcare system. This involvement creates a new avenue to convey library’s value.

    About the speaker Maylene Qiu

    Maylene is responsible for developing and providing systematic review services for the patrons principally from the health sciences schools at UPenn and the UPenn Healthcare System. She also serves as the Clinical Liaison Librarian promoting evidence-based medicine information resources and services.

    Before coming to Penn, Maylene was Clinical Reference Librarian at Quillen College of Medicine Library at East Tennessee State University, where she provided services for the clinicians at the Point-of-Care.

    Prior to the library field, she has 10-year experience in pharmaceutical science obtained from working in China, Japan, and Canada. In that career, she commercialized several products in nutrition and agriculture. She earned a B.S. in Pharmaceutical Science from the Nanjing University of Chinese Traditional Medicine, and an M.A. in the Library and Information Science from the University of Wisconsin – Madison.
Webinars supporting you to innovative, ensure compliance and safety
Realize the potential of data-driven drug discovery and development with solutions that help you increase research efficiency and ensure a thriving R&D pipeline.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Searching for adverse effects of medical devices in MEDLINE and Embase
  • Live at: Oct 18 2018 2:00 pm
  • Presented by: Dr Su Golder NIHR Research Fellow, Health Sciences, University of York
  • From:
Your email has been sent.
or close